NeoGenomics

NeoGenomics is a publicly traded precision oncology company and specialized clinical laboratory that provides comprehensive cancer diagnostic testing services to healthcare providers, biopharma partners, and oncology researchers. Founded in 1999 and headquartered in Fort Myers, Florida, the company has grown to a team of approximately 2,200 professionals spanning 13 locations across two continents, with more than 120 MDs and PhDs on staff. NeoGenomics delivers over 1.7 million cancer-related tests annually — including more than 100,000 next-generation sequencing (NGS) tests — drawing on one of the largest oncology databases with over 2 million unique patient profiles and serving approximately 4,400 medical sites and 500,000 patients per year. Its services span cytogenetics, flow cytometry, fluorescence in situ hybridization (FISH), molecular genetics, immunohistochemistry, and advanced pharma research services.